Searchable abstracts of presentations at key conferences in endocrinology

ea0062cb4 | Additional Cases | EU2019

Propylthiouracil-induced ANCA-associated vasculitis and agranulocytosis in a patient with Graves’ disease

Tomkins Maria , Smith Diarmuid , Agha Amar

42-year-old female with relapsing Graves’ disease treated with propylthiouracil (PTU) presented to the Emergency Department with a two-week history of fevers, night sweats, transient rash, arthralgia and fatigue. Five years previously she presented with Graves’ disease, TSH <0.02 mIU/l, FT4 of 39.8 pmol/l (9–16 pmol/l) and TSH receptor antibody positive with a titre of 11.3 IU/l. Initially treated with carbimazole therapy but developed an urticarial rash, lo...

ea0062p10 | Poster Presentations | EU2019

Metabolic encephalopathy secondary to diabetic ketoacidosis

Tomkins Maria , Richard McCormack , Karen O'Connell , Agha Amar , Merwick Aine

Case presentation: A 35-year-old man presented to the emergency department (ED) in a confused and agitated state. His past medical history was significant for poorly controlled type 1 diabetes, complicated by background diabetic retinopathy. He was taking basal/bolus insulin and had a history of diabetic ketoacidosis (DKA) eleven years prior. He also had multiple sclerosis however disengaged with neurology services and was non-compliant with interferon therapy. Prior to admiss...

ea0063p535 | Diabetes, Obesity and Metabolism 2 | ECE2019

Metabolic encephalopathy secondary to diabetic ketoacidosis

Tomkins Maria , McCormack Richard , O'Connell Karen , Agha Amar , Merwick Aine

Case presentation: A 35-year-old man presented to the emergency department (ED) in a confused and agitated state. His past medical history was significant for poorly controlled type 1 diabetes, complicated by background diabetic retinopathy. He was taking basal/bolus insulin and had a history of diabetic ketoacidosis (DKA) eleven years prior. He also had multiple sclerosis however disengaged with neurology services and was non-compliant with interferon therapy. Prior to admiss...